Products

MediAI-OA
Crescom Co., Ltd.
Clinical Decision Support & Reference
MediAI-OA is an AI diagnostic software developed by Crescom Co., Ltd. for evaluating osteoarthritis. It processes radiological images to improve analysis efficiency and accuracy, providing quantitative assessment of knee osteoarthritis severity.
MediAI-BA
Crescom
Radiology & Imaging AI
MediAI-BA is Crescom Co.'s AI-powered, web-based solution for automatic bone age analysis, skeletal maturity indication, and adult height prediction from X-ray images, utilizing a hybrid GP and TW3 algorithm.

See all 2 products →

About Crescom

Crescom is a healthcare technology company that specializes in developing and providing artificial intelligence (AI)-based medical image analysis solutions, with a strong focus on the musculoskeletal domain. Their products, such as the ‘MediAI’ series, are designed to assist medical professionals with diagnoses, aiming to significantly decrease analysis time and increase accuracy. For instance, their solutions aid in bone age analysis, fracture detection, and osteoarthritis severity analysis.

Crescom’s AI solutions are built to enhance medical benefits by helping doctors provide prompt and accurate diagnoses, delivering detailed analysis results with high accuracy. Their MediAI-BA software for bone age growth assessment, for example, has demonstrated a high level of accuracy comparable to specialists in clinical trials and has received US FDA 510(k) clearance. The company is actively engaged in global clinical validation programs, including a collaboration with Mass General Brigham in the United States, to establish clinical references and expand its presence in North American radiology and pediatric growth clinic markets. Crescom also offers an AI-powered platform for communication skills training.

Focus Areas

musculoskeletal AI medical imaging computer vision bone age analysis fracture detection osteoarthritis analysis scoliosis analysis ankylosing spondylitis pediatric growth prediction diagnostic AI radiology AI clinical decision support

Business Intelligence

TechnologyWeb-based AI software, hybrid artificial intelligence deep learning analysis technique, cloud or on-premise deployment via CARPL.ai marketplace

What Physicians Need to Know

Specialization
Crescom is a market leader specializing in musculoskeletal (MSK) AI solutions. Their 'MediAI' series focuses on analyzing medical imaging for conditions like bone age assessment, full lower-limb length measurement, scoliosis severity, and quantitative knee osteoarthritis analysis.
Key Differentiators
Crescom's solutions significantly decrease analysis time and increase accuracy for medical data. They have achieved global clinical validation with institutions like Mass General Brigham, demonstrating real-world usability and clinical efficacy. Their MediAI-BA bone age analysis AI has received FDA 510(k) clearance. They also have a highly regarded AI solution for severity classification of ankylosing spondylitis.
Technology Stack
While specific details of Crescom's full technology stack are not explicitly stated, general best practices for healthcare AI software often include programming languages like Python (for AI/ML with libraries like TensorFlow, PyTorch, Scikit-learn) and R (for statistical computing). Healthcare AI tech stacks prioritize secure processing of Protected Health Information (PHI), standards-based interoperability (FHIR, HL7), deterministic workflow orchestration, human-in-the-loop validation, auditability, traceability, high availability, and enterprise authentication/authorization.
Physician Tip

Crescom's AI tools are designed to enhance diagnostic accuracy and efficiency, particularly in musculoskeletal imaging. Physicians can expect significantly decreased time for medical data analysis and increased accuracy in diagnoses. The solutions aim to optimize operational workflows, especially in pediatric imaging where specialists are limited and imaging volumes are growing. The AI provides objective and consistent interpretation results, minimizing inter-reader variability and supporting rapid analysis, which is crucial for assessments like pediatric growth and development or orthodontic diagnosis. The clinical validation with leading institutions ensures the reliability and real-world applicability of these tools, potentially reducing physician burnout and improving overall productivity.

Seamless integration with existing EHRs (Electronic Health Records) and other healthcare databases is essential for AI-powered healthcare software. Crescom's focus on clinical validation and real-world usability suggests an understanding of the need for their solutions to fit into existing clinical workflows. Interoperability is a foundational challenge in healthcare AI, and successful adoption relies on the ability of AI tools to integrate effectively and provide accurate, usable data within the workflow where clinicians need it.

Products by Crescom

2 products in the directory

MediAI-OA
Crescom Co., Ltd.
Clinical Decision Support & Reference
MediAI-OA is an AI diagnostic software developed by Crescom Co., Ltd. for evaluating osteoarthritis. It processes radiological images to improve analysis efficiency and accuracy, providing quantitative assessment of knee osteoarthritis severity.
MediAI-BA
Crescom
Radiology & Imaging AI
MediAI-BA is Crescom Co.'s AI-powered, web-based solution for automatic bone age analysis, skeletal maturity indication, and adult height prediction from X-ray images, utilizing a hybrid GP and TW3 algorithm.

What the Web Says

Information about "Crescom" is limited and often conflated with other similarly named companies or products. There are some employee reviews for "CresCom Bank" which indicate a mixed but generally positive sentiment regarding culture and management, though some concerns about pay and benefits exist. Product reviews for a company explicitly named "Crescom" are scarce across major review platforms like G2, Capterra, and Glassdoor, with most search results pointing to other entities like "Crescent," "CrescoWorks," or "Crescendo."

Overall: Mixed

Strengths

  • Positive culture and management at CresCom Bank
  • Good work-life balance reported by some CresCom Bank employees
  • Opportunities for advancement at CresCom Bank
  • Digitized processes and reduced turnaround time for CrescoWorks

Limitations

  • Low pay and lack of direct deposit for some CresCom Bank employees
  • Underappreciation reported by some CresCom Bank employees
  • Limited product reviews specifically for "Crescom"
  • Difficulty in distinguishing "Crescom" from similarly named companies/products

Based on reviews from: Indeed.com, G2.com, Reddit, Capterra

Last updated: 2026-10-19

Videos

News, demos, and interviews about Crescom.

Loading videos...

Videos load interactively. If none appear, search YouTube for Crescom →

View all on YouTube

Press & Coverage

unknown
CRESCOM Obtains FDA 510(k) Clearance for Knee Osteoarthritis
Crescom announced FDA 510(k) clearance for its knee osteoarthritis AI solution, highlighting its focus on musculoskeletal diseases and continuous expansion of partnerships.
2026-06
PR Newswire
Crescom Launches Global PoC of Pediatric Musculoskeletal AI with Mass General Brigham
Crescom launched a global clinical Proof of Concept (PoC) for its pediatric musculoskeletal AI solutions in collaboration with the Department of Radiology at Mass General Brigham, covering bone age analysis, lower-limb length measurement, and scoliosis severity auto-measurement.
2026-06
BioSpectrum Asia
Korea's Crescom inks MoU with UKM Medical College in Malaysia for bone age analysis
Crescom signed a joint research agreement with the Faculty of Medicine at the National University of Malaysia (UKM) to verify the accuracy of its bone age analysis AI solution, 'MediAI-BA', in clinical settings.
2026-08
PR Newswire
Crescom to Showcase Musculoskeletal AI Innovations at 26th Asian Musculoskeletal Society Annual Meeting
Crescom announced its participation in the 26th Asian Musculoskeletal Society (AMS) Annual Meeting to showcase its MediAI solution suite and strengthen partnerships for expansion across Southeast and East Asia.
2025-08
Innolitics
AI/ML Medical Device FDA Clearances Week 52 2025
Crescom Co. Ltd. received FDA clearance for MediAI-BA, an AI-powered pediatric bone age analysis tool that evaluates bone age and predicted adult height from hand and wrist X-ray images.
2025-12
Samitivej Hospital
Samitivej and BNH Hospitals Sign MOU with South Korean NIPA and Crescom for Medical AI Software Development
Samitivej Children's Hospital implemented Crescom's medical AI software for analyzing and predicting bone growth in children, aiming to enhance precocious puberty treatment by reducing analysis time and increasing diagnostic accuracy.
2023-11

Frequently Asked Questions

Crescom offers a suite of AI-powered musculoskeletal solutions, including MediAI-BA for bone age analysis and adult height prediction, MediAI-OA for quantitative knee osteoarthritis assessment, and MediAI-FX for scaphoid fracture detection. They also have solutions for full lower-limb length measurement (MediAI-SG) and scoliosis severity auto-measurement (MediAI-SC), with others in the pipeline for conditions like ankylosing spondylitis.
Yes, Crescom's MediAI-BA, their bone age analysis AI solution, has received FDA 510(k) clearance in the United States, as well as regulatory approvals in Korea, Thailand, and Malaysia. Their MediAI-OA solution for knee osteoarthritis analysis has also received FDA 510(k) clearance.
Crescom emphasizes clinical validation and collaboration with leading institutions. For example, they launched a global clinical Proof of Concept (PoC) for their pediatric musculoskeletal AI solutions with the Department of Radiology at Mass General Brigham, where radiologists compare AI-generated readings against expert clinical interpretations. Their MediAI-BA uses a patented hybrid analysis algorithm combining GP and TW3 methods for accurate bone age assessment.
Crescom's MediAI-BA is supported by multiple peer-reviewed papers, and studies have shown its accuracy in bone age assessment, with a mean absolute difference of 0.39 years compared to specialist assessments. The company is actively engaged in clinical validation studies with institutions like Mass General Brigham to demonstrate improved reading efficiency and clinical utility.
Crescom is actively expanding its presence in North America through collaborations like the one with Mass General Brigham, which is expected to establish a robust clinical track record in the North American radiology and pediatric growth clinic markets. They also plan to integrate their pediatric solutions with the North American youth athletic development industry.
While specific financial details are limited, Crescom is described as a medical AI company specializing in musculoskeletal analysis, with a strong focus on innovation and efficiency in medical data analysis. Their ongoing clinical validations with prominent institutions and expansion into new markets suggest a strategic approach to growth and stability in the healthcare AI sector.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.